安徽医药
安徽醫藥
안휘의약
ANHUI MEDICAL AND PHARMACEUTICAL JOURNAL
2014年
8期
1475-1477
,共3页
黄小伟%王飞%聂森%沈晓霞%吴洁
黃小偉%王飛%聶森%瀋曉霞%吳潔
황소위%왕비%섭삼%침효하%오길
胸腔积液%癌胚抗原%腺苷脱氨酶
胸腔積液%癌胚抗原%腺苷脫氨酶
흉강적액%암배항원%선감탈안매
pleural effusion%CEA%ADA
目的:探讨联合胸水癌胚抗原(CEA)、腺苷脱氨酶(ADA)检测在结核性渗出性胸膜炎及恶性胸腔积液中的意义。方法回顾性分析2008年1月-2013年1月在该院住院期间,诊断为结核性渗出性胸膜炎、恶性胸腔积液的148例患者,检测胸腔积液中的CEA及ADA含量,并加以ROC分析。结果在恶性胸腔积液的诊断方向上,ADA和CEA两种指标/方法,灵敏度分别为0.857和0.976,特异度均为1.000,诊断阈值分别为18 U·L-1和2.8μg·L-1,两种方法经配对检验无显著性差异。结论联合检测胸水CEA及ADA对于鉴别结核性渗出性胸膜炎与恶性胸腔积液有着至关重要的意义。
目的:探討聯閤胸水癌胚抗原(CEA)、腺苷脫氨酶(ADA)檢測在結覈性滲齣性胸膜炎及噁性胸腔積液中的意義。方法迴顧性分析2008年1月-2013年1月在該院住院期間,診斷為結覈性滲齣性胸膜炎、噁性胸腔積液的148例患者,檢測胸腔積液中的CEA及ADA含量,併加以ROC分析。結果在噁性胸腔積液的診斷方嚮上,ADA和CEA兩種指標/方法,靈敏度分彆為0.857和0.976,特異度均為1.000,診斷閾值分彆為18 U·L-1和2.8μg·L-1,兩種方法經配對檢驗無顯著性差異。結論聯閤檢測胸水CEA及ADA對于鑒彆結覈性滲齣性胸膜炎與噁性胸腔積液有著至關重要的意義。
목적:탐토연합흉수암배항원(CEA)、선감탈안매(ADA)검측재결핵성삼출성흉막염급악성흉강적액중적의의。방법회고성분석2008년1월-2013년1월재해원주원기간,진단위결핵성삼출성흉막염、악성흉강적액적148례환자,검측흉강적액중적CEA급ADA함량,병가이ROC분석。결과재악성흉강적액적진단방향상,ADA화CEA량충지표/방법,령민도분별위0.857화0.976,특이도균위1.000,진단역치분별위18 U·L-1화2.8μg·L-1,량충방법경배대검험무현저성차이。결론연합검측흉수CEA급ADA대우감별결핵성삼출성흉막염여악성흉강적액유착지관중요적의의。
Objective To discuss the value of combined detection of pleural effusion CEA and ADA in tuberculous exudative pleurisy and malignant pleural effusion.Methods A retrospective study was made of 104 patients with tuberculous exudative pleurisy and ma-lignant pleural effusion admitted to No.98 Hospitla of PLA from January ,2008 to January,2013.Pleural effusion CEA and ADA levels were detected and ROC analysis was made.Results From the malignant pleural effusion diagnostic standpoint,the sensitivities of ADA and CEA were 0.857 and 0.976,the specificities were both 1,and the diagnostic thresholds were 18 U·L-1and 2.8 μg·L-1,respec-tively.The two methods had no significant difference by paired test.Conclusions The combined detection of pleural effusion CEA and ADA has crucial importance to tuberculous exudative pleurisy and malignant pleural effusion.